Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Interactive effects of 9-cis-retinoic acid and androgen on proliferation, differentiation, and apoptosis of LNCaP prostate cancer cells.

Eskra JN, Kuiper JW, Walden PD, Bosland MC, Özten N.

Eur J Cancer Prev. 2017 Jan;26(1):71-77.

PMID:
26886237
2.

Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein.

Kawakubo H, Brachtel E, Hayashida T, Yeo G, Kish J, Muzikansky A, Walden PD, Maheswaran S.

Cancer Res. 2006 Jul 15;66(14):7075-82.

3.

Regulation of de novo phosphatidylinositol synthesis.

Nuwayhid SJ, Vega M, Walden PD, Monaco ME.

J Lipid Res. 2006 Jul;47(7):1449-56. Epub 2006 May 1.

4.

BMP7 inhibits branching morphogenesis in the prostate gland and interferes with Notch signaling.

Grishina IB, Kim SY, Ferrara C, Makarenkova HP, Walden PD.

Dev Biol. 2005 Dec 15;288(2):334-47.

5.

SOM230 inhibits insulin-like growth factor-I action in mammary gland development by pituitary independent mechanism: mediated through somatostatin subtype receptor 3?

Ruan W, Fahlbusch F, Clemmons DR, Monaco ME, Walden PD, Silva AP, Schmid HA, Kleinberg DL.

Mol Endocrinol. 2006 Feb;20(2):426-36. Epub 2005 Oct 13.

PMID:
16223973
6.

Coexpression of MAST205 inhibits the activity of Na+/H+ exchanger NHE3.

Wang D, Lee HJ, Cooper DS, Cebotaro L, Walden PD, Choi I, Yun CC.

Am J Physiol Renal Physiol. 2006 Feb;290(2):F428-37. Epub 2005 Sep 13.

7.

Effect of neurokinins on canine prostate cell physiology.

Walden PD, Marinese D, Srinivasan D, Tzoumaka E, Syyong HT, Ford AP, Bhattacharya A.

Prostate. 2005 Jun 1;63(4):358-68.

PMID:
15611996
8.

Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer.

Kawakubo H, Carey JL, Brachtel E, Gupta V, Green JE, Walden PD, Maheswaran S.

Oncogene. 2004 Oct 28;23(50):8310-9.

PMID:
15378000
9.

The cooperative prostate cancer tissue resource: a specimen and data resource for cancer researchers.

Melamed J, Datta MW, Becich MJ, Orenstein JM, Dhir R, Silver S, Fidélia-Lambert M, Kadjacsy-Balla A, Macias V, Patel A, Walden PD, Bosland MC, Berman JJ.

Clin Cancer Res. 2004 Jul 15;10(14):4614-21.

10.
11.

Lipid metabolism in phosphatidylinositol transfer protein alpha-deficient vibrator mice.

Monaco ME, Kim J, Ruan W, Wieczorek R, Kleinberg DL, Walden PD.

Biochem Biophys Res Commun. 2004 Apr 30;317(2):444-50.

PMID:
15063778
12.

Microtubule-associated serine/threonine kinase-205 kDa and Fc gamma receptor control IL-12 p40 synthesis and NF-kappa B activation.

Zhou H, Xiong H, Li H, Plevy SE, Walden PD, Sassaroli M, Prestwich GD, Unkeless JC.

J Immunol. 2004 Feb 15;172(4):2559-68.

13.

ART-27, an androgen receptor coactivator regulated in prostate development and cancer.

Taneja SS, Ha S, Swenson NK, Torra IP, Rome S, Walden PD, Huang HY, Shapiro E, Garabedian MJ, Logan SK.

J Biol Chem. 2004 Apr 2;279(14):13944-52. Epub 2004 Jan 7.

14.

Chronic lymphocytic leukemia with prostate infiltration mediated by specific clonal membrane-bound IgM.

Bogdan CA, Alexander AA, Gorny MK, Matute R, Marjanovic N, Zolla-Pazner S, Walden PD, Furneaux HM, Sidhu GS, Jacobson DR.

Cancer Res. 2003 May 1;63(9):2067-71.

15.

Chemoprevention strategies for prostate cancer.

Bosland MC, McCormick DL, Melamed J, Walden PD, Zeleniuch-Jacquotte A, Lumey LH.

Eur J Cancer Prev. 2002 Aug;11 Suppl 2:S18-27. Review.

PMID:
12570331
16.

Mechanistic investigation of the adrenergic induction of ventral prostate hyperplasia in mice.

Marinese D, Patel R, Walden PD.

Prostate. 2003 Feb 15;54(3):230-7.

PMID:
12518328
17.

Analysis of hormone-stimulated phosphatidylinositol synthesis.

Monaco ME, Moldover NH, Walden PD.

J Cell Physiol. 2003 Feb;194(2):151-61.

PMID:
12494453
18.

BTG2(TIS21/PC3) induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells.

el-Ghissassi F, Valsesia-Wittmann S, Falette N, Duriez C, Walden PD, Puisieux A.

Oncogene. 2002 Oct 3;21(44):6772-78.

19.

Evaluation of the adequacy of published studies of low-dose effects of bisphenol A on the rodent prostate for use in human risk assessment.

Milman HA, Bosland MC, Walden PD, Heinze JE.

Regul Toxicol Pharmacol. 2002 Jun;35(3):338-46.

PMID:
12202049
20.

Expression of B-cell translocation gene 2 protein in normal human tissues.

Melamed J, Kernizan S, Walden PD.

Tissue Cell. 2002 Feb;34(1):28-32.

PMID:
11989967
21.

Hand-held portable sonography for the on-mountain exclusion of a pneumothorax.

Kirkpatrick AW, Brown DR, Crickmer S, Mohr BP, Hamilton DR, Cunningham J, Walden PD, Nicolaou S.

Wilderness Environ Med. 2001 Winter;12(4):270-2. No abstract available.

PMID:
11769924
22.

Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis.

Ficazzola MA, Fraiman M, Gitlin J, Woo K, Melamed J, Rubin MA, Walden PD.

Carcinogenesis. 2001 Aug;22(8):1271-9.

PMID:
11470758
23.

Expression of the ET(A) and ET(B) endothelin receptor subtype mRNA in human detrusor cultured smooth muscle cells.

Obara K, Walden PD, Hatano A, Tomita Y, Takahashi K, Lepor H.

Urol Int. 2000;65(2):68-72.

PMID:
11025426
24.

Interactions between beta 2-syntrophin and a family of microtubule-associated serine/threonine kinases.

Lumeng C, Phelps S, Crawford GE, Walden PD, Barald K, Chamberlain JS.

Nat Neurosci. 1999 Jul;2(7):611-7.

PMID:
10404183
25.

Mitogenic activation of human prostate-derived fibromuscular stromal cells by bradykinin.

Walden PD, Lefkowitz GK, Ittmann M, Lepor H, Monaco ME.

Br J Pharmacol. 1999 May;127(1):220-6.

26.
28.

Identification of genes associated with stromal hyperplasia and glandular atrophy of the prostate by mRNA differential display.

Walden PD, Lefkowitz GK, Ficazzola M, Gitlin J, Lepor H.

Exp Cell Res. 1998 Nov 25;245(1):19-26.

PMID:
9828097
29.

Evidence that mammalian phosphatidylinositol transfer protein regulates phosphatidylcholine metabolism.

Monaco ME, Alexander RJ, Snoek GT, Moldover NH, Wirtz KW, Walden PD.

Biochem J. 1998 Oct 1;335 ( Pt 1):175-9.

30.

Localization of P2Y1 purinoceptor transcripts in the rat penis and urinary bladder.

Obara K, Lepor H, Walden PD.

J Urol. 1998 Aug;160(2):587-91.

PMID:
9679933
32.

Evidence that the mammary fat pad mediates the action of growth hormone in mammary gland development.

Walden PD, Ruan W, Feldman M, Kleinberg DL.

Endocrinology. 1998 Feb;139(2):659-62.

PMID:
9449638
33.
34.

Localization of mRNA and receptor binding sites for the alpha 1a-adrenoceptor subtype in the rat, monkey and human urinary bladder and prostate.

Walden PD, Durkin MM, Lepor H, Wetzel JM, Gluchowski C, Gustafson EL.

J Urol. 1997 Mar;157(3):1032-8.

PMID:
9072538
35.
36.

The alpha-adrenoceptor antagonist properties of the enantiomers of doxazosin in the human prostate.

Hatano A, Tang R, Walden PD, Lepor H.

Eur J Pharmacol. 1996 Oct 10;313(1-2):135-43.

PMID:
8905340
37.

A novel cochaperonin that modulates the ATPase activity of cytoplasmic chaperonin.

Gao Y, Melki R, Walden PD, Lewis SA, Ampe C, Rommelaere H, Vandekerckhove J, Cowan NJ.

J Cell Biol. 1994 Jun;125(5):989-96.

39.
40.

Structure and expression of an alpha-tubulin gene of Physarum polycephalum.

Walden PD, Monteiro MJ, Gull K, Cox RA.

Eur J Biochem. 1989 May 15;181(3):583-92.

Supplemental Content

Loading ...
Support Center